Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.4831
-0.0880 (-15.41%)
At close: Nov 18, 2026, 4:00 PM EST
0.5001
+0.0170 (3.52%)
Pre-market: Nov 19, 2026, 7:07 AM EST
Celularity Employees
Celularity had 115 employees as of December 31, 2025. The number of employees decreased by 8 or 6.50% compared to the previous year. That makes Celularity the 30,568th largest employer in the world and 3,878th in the United States.
Employees
115
Change (1Y)
-8
Growth (1Y)
-6.50%
Revenue / Employee
$162,313
Profits / Employee
-$402,061
Market Cap
15.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115 | -8 | -6.50% |
| Dec 31, 2024 | 123 | 3 | 2.50% |
| Dec 31, 2023 | 120 | -105 | -46.67% |
| Dec 31, 2022 | 225 | 0 | - |
| Dec 31, 2021 | 225 | 63 | 38.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Seres Therapeutics | 66 |
| Context Therapeutics | 15 |
| Lipocine | 14 |
| NewcelX | 12 |
| Akari Therapeutics, | 6 |
| Quoin Pharmaceuticals | 6 |
| Pasithea Therapeutics | 5 |
CELU News
- 6 days ago - Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development - Newsfile Corp
- 9 days ago - Celularity Proxy statement: Proxy filing - Filings
- 9 days ago - Celularity Proxy statement: Proxy filing - Filings
- 20 days ago - Celularity, Vesalius Longevity Labs signs exclusive collaboration for Peptual - TheFly
- 20 days ago - Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States - Business Wire
- 21 days ago - Celularity Proxy statement: Proxy filing - Filings
- 4 weeks ago - Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement - GlobeNewsWire
- 4 weeks ago - Celularity Quarterly report: Q2 2026 - Filings